Previous whole-genome CRISPR screening demonstrated the fibroblast growth factor receptor 1 (FGFR1) as the top-ranked target that promoting the survival of mesenchymal phenotype-related cancer cells 52. This evidence concerns the gene FGFR1 and cancer.